ReviewMediterranean journal of hematology and infectious diseases2016

BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia.

Lorenzo Falchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.